inspect molecule / saxenda
Saxenda
Liraglutide o==o / \ GLP1 \____/
Liraglutide is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.
active moietyLiraglutide
administration routeSubcutaneous
price comparison status3 snapshots
safety signal rating78 / 100
GLP-1 Receptor Agonist [EPC]openFDA NDC seedopenFDA NDC6 mg/mL
price index
Ingredient Reference Prices
⚠ Direct price snapshots for this brand/package are not staged yet. Showing verified reference prices for active ingredient: Liraglutide.
$1,830USvsCA$514.79CA
- Cost Plus Drugs · US$87.80
2 pens × 3mL (30-day supply) · cash · Cost Plus Drugs liraglutide ↗
- PharmaServe reference · US$1,830
retail reference · retail-reference · PharmaServe US retail comparison ↗
- PharmaServe Canada · CACA$514.79
listing reference · cash · PharmaServe popular medications ↗
Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.
query trend --id 8330 --12m
Price Trend Index
Deterministic trailing 12-month value delta index for this active ingredient class.
Rising Fast3M: +2.6%12M: +0.4%
Jul 2025Jun 2026
Jan 2026$85.43
Feb 2026$84.56
Mar 2026$84.22
Apr 2026$84.05
May 2026$85.03
Jun 2026$86.40
01 / chemistryNovo Nordisk Pharmaceutical Industries, LP
Ingredient Breakdown
active moietyLiraglutide
formulationSubcutaneous GLP-1 Receptor Agonist [EPC]
mechanism of action
GLP-1 Receptor Agonist [EPC]
available strengths
6 mg/mL
02 / ingredientsexcipients
Excipients / Maker Notes
- Not enriched yet from label source.
Manufacturer Notes
- This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals
Steps To Take Safely
- Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
- Read the official label for route-specific directions, contraindications, and storage.
- Ask a clinician or pharmacist before substituting products across countries or formulations.
- Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.
Side-Effect Signals
- nausea / vomiting
- diarrhea or constipation
- abdominal pain
- low blood sugar risk with insulin/sulfonylureas
- rare pancreatitis/gallbladder warning
Summary of index signals. Not active medical advice. Consult official labels and clinicians.
$ grep ingredient --same